NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners ...
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX™ GBS ...
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today the U.S. Food and Drug Administration (FDA) clearance of the BD MAX™ Group B Streptococcus (GBS) Assay and Clinical Laboratory ...
COPENHAGEN, Denmark, Jan. 5, 2023 /PRNewswire/ -- MinervaX ApS, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces the ...
Mumbai: The Minister of Medical Education, Hasan Mushrif, on Tuesday called for the effective implementation of Standard Operating Procedures (SOPs) to curb the spread of the Guillain-Barré Syndrome ...
Guillain-Barré Syndrome, or GBS, is a rare neurological condition. The body's immune system mistakenly attacks its own nerves ...
In the light of Guillain-Barre Syndrome (GBS) cases reported across the country, the Directorate of Public Health (DPH) and Preventive Medicine has instructed health officers to strengthen ...
Mumbai: Amid the outbreak of Guillain-Barre Syndrome (GBS), Maharashtra Chief Minister Devendra Fadnavis has asked the administration to make special arrangements in government hospitals to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback